HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

subetta

has hypoglycemic activity; a mixture of antibodies against endothelial nitric oxide synthase and insulin receptor beta-subunit

Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        subetta: 4
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        subetta: 4
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        subetta: 4

Experts

1.	Mkrtumyan, Ashot: 2 articles (03/2022 - 08/2018)
2.	Volkova, Anna: 2 articles (03/2022 - 08/2018)
3.	Vorobiev, Sergei: 2 articles (03/2022 - 08/2018)
4.	Ametov, Alexander: 1 article (03/2022)
5.	Demidova, Tatiana: 1 article (03/2022)
6.	Dudinskaya, Ekaterina: 1 article (03/2022)
7.	Vertkin, Arkady: 1 article (03/2022)
8.	Andrianova, Elena: 1 article (08/2018)
9.	Epstein, Oleg: 1 article (08/2018)
10.	Putilovskiy, Mikhail: 1 article (08/2018)

Related Diseases

1.	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/01/2018 - "Efficacy and safety of Subetta add-on therapy in type 1 diabetes mellitus: The results of a multicenter, double-blind, placebo-controlled, randomized clinical trial." 08/01/2018 - "To examine efficacy of Subetta as an add-on to insulin therapy in patients with type 1 diabetes mellitus (T1DM) a multicenter, double-blind, placebo-controlled, randomized clinical trial was performed. "
2.	Diabetes Mellitus 05/01/2012 - "Antidiabetic activity of Subetta was revealed on the model of streptozotocin-induced diabetes mellitus in rats. " 05/01/2012 - "Study of hypoglycemic activity of Subetta and rosiglitazone on the model of streptozotocin-induced diabetes mellitus in rats."
3.	Insulin Resistance 03/03/2022 - "A New Approach to Overcome Insulin Resistance in Patients with Impaired Glucose Tolerance: The Results of a Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety of Subetta." 08/01/2015 - "These findings suggest that Subetta significantly enhanced insulin sensitivity of tissues through stimulation of glucose transport to myocytes mediated by glucose transporter 4."
4.	Glucose Intolerance 03/03/2022 - "A New Approach to Overcome Insulin Resistance in Patients with Impaired Glucose Tolerance: The Results of a Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety of Subetta."
5.	Hypoglycemia (Reactive Hypoglycemia) 08/01/2018 - "The rate of overall hypoglycemia events was 7.9 per patient year (95% CI 7.1-8.6) in Subetta group and 7.6 (95% CI 6.9-8.4) in Placebo group (p = 0.63). "

Related Drugs and Biologics

1.	Insulin (Novolin)
2.	Streptozocin (Streptozotocin)
3.	Hypoglycemic Agents (Hypoglycemics)
4.	Rosiglitazone (Avandia)
5.	Facilitative Glucose Transport Proteins (Glucose Transporter)
6.	Glucose (Dextrose)

Related Therapies and Procedures

1.	Therapeutics